An unspoken war has been waged between India and the U.S. at the COP21 Summit in Paris. If the West wants India to opt for more expensive energy options, then they must also reciprocate by sharing technology.
The U.S. is urging India to alter its IPR regime, and the potential impact on prices in the pharmaceuticals sector is of concern to African countries that depend on India for low-cost generic medicines. The recent India-Africa Forum Summit in New Delhi sought to address this issue, but it will be a challenge for India to balance competing pressures.
With a decisive mandate for economic deliverance the new government will have to rapidly do more than just provide inclusive growth. It will have to foster a market culture that makes economic democracy possible
Policy Perspectives from Gateway House give an overview of a global issue that has implications for India’s policy-making and business community. This edition focuses on the global IPR framework and the need for new business models that can cater to public health concerns
The Indian Supreme Court’s verdict in the Novartis case over patent rights has opened up the debate on intellectual property rights (IPR) in India, and globally. Gateway House interviews Narendra Sabharwal, Chair, IPR Committee, FICCI, to discuss the role of IPR and public health concerns in emerging economies.
Negotiations for the India-EU Free Trade Agreement, which began in 2007, have yet to conclude. Deepak Rao blogs about the factors delaying the process, and the implications of the agreement on different sectors of the economy.
Often, many vital inventions are left incomplete or do not reach the market as information is locked up by numerous patent holders. How does this hamper innovation, and why is it necessary to overcome the attitude of ‘anti-commons’ and foster cross-fertilization of knowledge?